Simplify your online presence. Elevate your brand.

Vkh

Ppt Vogt Koyanagi Harada Vkh Syndrome Powerpoint Presentation
Ppt Vogt Koyanagi Harada Vkh Syndrome Powerpoint Presentation

Ppt Vogt Koyanagi Harada Vkh Syndrome Powerpoint Presentation Vkh disease is a bilateral granulomatous panuveitis affecting young adults of color. it causes uveitis, retinal detachment, vitiligo, and hearing loss. learn about its epidemiology, pathogenesis, clinical features, diagnosis, and treatment. Vogt–koyanagi–harada disease vogt–koyanagi–harada disease (vkh) is a multisystem disease of presumed autoimmune cause that affects melanin pigmented tissues.

Vogt Koyanagi Harada Disease Vkh December 2021 Illinois Retina
Vogt Koyanagi Harada Disease Vkh December 2021 Illinois Retina

Vogt Koyanagi Harada Disease Vkh December 2021 Illinois Retina The exact cause of vkh disease is unknown, but the symptoms are thought to be due to an abnormal response of the immune system to a viral infection. genetic factors may be involved. diagnosis of vkh disease is based on the symptoms, clinical exam, and imaging studies. Vkh syndrome is a t cell driven autoimmune disease that affects melanocytes and causes bilateral granulomatous panuveitis and other symptoms in the eyes, ears, skin and nervous system. learn about its epidemiology, clinical presentation, diagnosis and treatment options in this article. What is vogt koyanagi harada disease? vogt koyanagi harada disease (vkh) is a rare condition that causes inflammation and damage throughout your body. it’s also known as vogt koyanagi harada syndrome. Consensus is lacking on the best initial treatment approach to vogt koyanagi harada disease (vkh), an autoimmune condition accompanied by bilateral granulomatous panuveitis, with or without involvement of neurologic, auditory, or integumentary systems.

Vogt Koyanagi Harada Disease Vkh December 2021 Illinois Retina
Vogt Koyanagi Harada Disease Vkh December 2021 Illinois Retina

Vogt Koyanagi Harada Disease Vkh December 2021 Illinois Retina What is vogt koyanagi harada disease? vogt koyanagi harada disease (vkh) is a rare condition that causes inflammation and damage throughout your body. it’s also known as vogt koyanagi harada syndrome. Consensus is lacking on the best initial treatment approach to vogt koyanagi harada disease (vkh), an autoimmune condition accompanied by bilateral granulomatous panuveitis, with or without involvement of neurologic, auditory, or integumentary systems. Vkh is more prevalent in patients with a darker skin pigmentation than in caucasians and people of turkish descent. patients with vkh are most commonly of asian, hispanic, indian, native american, or mediterranean origin [2]. Differentiation between vkh and infectious chorioretinitis is particularly critical, given that corticosteroid therapy, essential in vkh, may worsen infectious chorioretinitis by promoting the development of subretinal fibrosis and macular scarring. Treatment goals in vkh include early diagnosis and suppression of active inflammation, along with prevention of recurrent inflammation and vision threatening complications, such as glaucoma, bullous retinal detachment, and choroidal neovascularization. Vkh disease is a rare disorder that affects the eyes, ears, nervous system, and skin. it may be caused by an abnormal immune response to a viral infection and is treated with corticosteroids and other medications.

Vogt Koyanagi Harada Disease Vkh December 2021 Illinois Retina
Vogt Koyanagi Harada Disease Vkh December 2021 Illinois Retina

Vogt Koyanagi Harada Disease Vkh December 2021 Illinois Retina Vkh is more prevalent in patients with a darker skin pigmentation than in caucasians and people of turkish descent. patients with vkh are most commonly of asian, hispanic, indian, native american, or mediterranean origin [2]. Differentiation between vkh and infectious chorioretinitis is particularly critical, given that corticosteroid therapy, essential in vkh, may worsen infectious chorioretinitis by promoting the development of subretinal fibrosis and macular scarring. Treatment goals in vkh include early diagnosis and suppression of active inflammation, along with prevention of recurrent inflammation and vision threatening complications, such as glaucoma, bullous retinal detachment, and choroidal neovascularization. Vkh disease is a rare disorder that affects the eyes, ears, nervous system, and skin. it may be caused by an abnormal immune response to a viral infection and is treated with corticosteroids and other medications.

Comments are closed.